William Blair Downgrades Agile Therapeutics (AGRX) to Market Perform
Tweet Send to a Friend
William Blair downgraded Agile Therapeutics (NASDAQ: AGRX) from Outperform to Market Perform.Analyst Tim Lugo believes ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
